Ghent University Hospital
🇧🇪Belgium
Assessment of the Blink (First) Impression Regarding the Presence of Cancer Within Colorectal Polyps
Completed
- Conditions
- Colorectal PolypColorectal CancerColono
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2023-04-24
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 191
- Registration Number
- NCT05699954
- Locations
- 🇧🇪
UZ Gent, Ghent, Belgium
Risk Factors and Etiologies of Epilepsy in Urban and Rural Rwanda
Completed
- Conditions
- Epilepsy
- Interventions
- Diagnostic Test: Blood sampleDiagnostic Test: EEGDiagnostic Test: NeuroimagingOther: Risk factor questionnaire
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 1745
- Registration Number
- NCT05698537
- Locations
- 🇷🇼
King Faisal Hospital, Kigali, Rwanda
Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study
Not Applicable
Recruiting
- Conditions
- Lung NeoplasmsPET-CT Specimen Imager
- Interventions
- Device: AURA10 Specimen Imager
- First Posted Date
- 2023-01-23
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 40
- Registration Number
- NCT05693363
- Locations
- 🇧🇪
University Hospital Ghent, Ghent, Belgium
Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers
Recruiting
- Conditions
- Esophageal Neoplasms
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 100
- Registration Number
- NCT05688176
- Locations
- 🇧🇪
University hospital Ghent, Ghent, Oost-Vlaanderen, Belgium
Multiple Sclerosis Prediction and Monitoring of Progression Study
Not Applicable
Recruiting
- Conditions
- Progressive Multiple Sclerosis
- Interventions
- Device: Bytelfies kit - sensor dot
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2024-01-08
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 70
- Registration Number
- NCT05685784
- Locations
- 🇧🇪
University Hospital Ghent, Ghent, Oost-Vlaanderen, Belgium
Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS)
Phase 4
Recruiting
- Conditions
- Psoriasis Vulgaris
- Interventions
- Procedure: VenapunctureProcedure: Patient questionnaires
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2024-02-05
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 100
- Registration Number
- NCT05685940
- Locations
- 🇧🇪
Private practice Dermatology, Maldegem, East-Flanders, Belgium
🇧🇪AZ Maria Middelares, Ghent, East-Flanders, Belgium
🇧🇪AZ Sint-Jan, Brugge, West-Flanders, Belgium
BELgian CT-perFUSion Study to Select Acute Stroke Patients for Thrombectomy
Not Applicable
Withdrawn
- Conditions
- Stroke, IschemicStrokeStroke, Acute
- Interventions
- Device: perfusion CT
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- University Hospital, Ghent
- Registration Number
- NCT05685043
A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated
Phase 4
Completed
- Conditions
- Psoriasis
- Interventions
- Procedure: VenapunctureBiological: Dose tapering of adalimumab in patients with supratheurapeutic serum trough levelsOther: Dermatology Life Quality Index (DLQI)Other: EQ-5D-5L questionnaireProcedure: Dried blood spot sampling
- First Posted Date
- 2023-01-12
- Last Posted Date
- 2023-01-12
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 19
- Registration Number
- NCT05683054
- Locations
- 🇧🇪
University Hospital, Ghent, Belgium
Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy
Not Applicable
Recruiting
- Conditions
- Myoma
- Interventions
- Device: Hyalobarrier
- First Posted Date
- 2023-01-12
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 30
- Registration Number
- NCT05683041
- Locations
- 🇧🇪
University Hospital Ghent, Ghent, Belgium
Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients
Phase 4
Recruiting
- Conditions
- Psoriasis Vulgaris
- Interventions
- Procedure: VenapunctureProcedure: Patient questionnaires
- First Posted Date
- 2023-01-12
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 100
- Registration Number
- NCT05683015
- Locations
- 🇧🇪
University Hospital Ghent, Ghent, Belgium
© Copyright 2025. All Rights Reserved by MedPath